| Document |
Document Title |
|
WO/2018/065795A1 |
A system of multivitamin and mineral compositions is provided for carrying out an administration regime in a woman being in the reproductive age, said system comprising compositions adjusted to the phases of the menstrual cycle and the s...
|
|
WO/2018/064544A1 |
A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an exten...
|
|
WO/2018/064468A1 |
Disclosed herein are methods and compositions for treating, inhibiting, or reducing hair loss, treating, inhibiting, or reducing pigmentation loss, improving or stimulating hair growth, and/or improving or stimulating pigmentation produc...
|
|
WO/2018/060174A1 |
The invention relates to substituted benzimidazoles of formula (I), to the use thereof for treating and/or preventing diseases, and to the use thereof for producing drugs for treating and/or preventing diseases, in particular for treatin...
|
|
WO/2018/064238A1 |
The addition of a salt to an ALA formulation reduces the degree of burning or irritation from ALA exposure during administration. This is particularly useful for an oral dissolve form of administration due to the extended time of ALA exp...
|
|
WO/2018/056461A1 |
The present invention addresses the issue of providing a means to ameliorate deterioration in the quality of preimplantation embryos as a result of aging, etc. The present invention pertains to an agent for improving the quality of eggs,...
|
|
WO/2018/056409A1 |
The present invention addresses the problem of providing a preparation effective in preventing and/or ameliorating reduction in ovarian function. Provided is an agent for preventing or ameliorating reduction in ovarian function, comprisi...
|
|
WO/2018/052848A1 |
Artificial cervical fluid is disclosed that contains a mucilaginous extract from the okra plant. The mucilaginous extract can be produced using a hot aqueous extractant or cold extraction process followed by separation of larger particle...
|
|
WO/2018/041790A1 |
The present invention relates to an oral composition comprising one or more extracts originating from a plant material chosen from pollen and/or pistils originating from plants belonging to the Gramineae (Poaceae) and/or Pinaceae family....
|
|
WO/2018/041268A1 |
Disclosed is a nanobody vaginal administration system, comprising a specific nanobody with biological activity and an antibody drug carrier that increases the stability and tissue penetrability of the nanobody, and the drug carrier inclu...
|
|
WO/2018/035751A1 |
A Cordyceps sinensis health supplement containing traditional Chinese medicine extracts and a preparation method therefor. The health supplement comprises the following raw materials in parts by weight: 20-40 parts of Folium Mori extract...
|
|
WO/2018/038180A1 |
The present invention addresses the problem of providing a technology that is useful for the progress in reproductive medicine and fertilized egg transplantation. Provided are: a sperm activator that contains, as an active ingredient, a ...
|
|
WO/2018/034227A1 |
Provided is an anti-LAG-3 antibody that can be frequently administered to a non-rat animal. The anti-LAG-3 antibody comprises: (a) an L chain comprising an L-chain variable region that includes CDR1 having a QSLLDSDGNTY (SEQ ID NO. 16) a...
|
|
WO/2018/033759A1 |
This invention relates to a dosage regimen comprising 4,4'-[fluoro-(1-H-1,2,4-triazol-1-yl)methylene]bisbenzonitri
le and a combined oral contraceptive for use in the treatment of endometriosis in a non-pregnant, pre-menopausal female. T...
|
|
WO/2018/030317A1 |
The present invention addresses the problem of providing a drug that reduces the risk of a reduction in bone mineral content associated with the hypoestrogenic effect, and that exhibits an excellent therapeutic effect with respect to end...
|
|
WO/2018/025165A1 |
A medicament comprising a parsley extract for use in the treatment and/or prevention of endometriosis is described. The medicament may also comprise an oleander extract.
|
|
WO/2018/024224A1 |
A nitrogen-containing tricyclic compound which acts as modulator of FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the ...
|
|
WO/2018/025982A1 |
Provided is a treatment method etc. for example against novel IL-8 related diseases, using an IL-8 signal inhibitor. Alternatively, provided is a treatment method etc. for example against known or novel IL-8 related diseases, using a nov...
|
|
WO/2018/024912A1 |
The present invention relates to a method for the management of dysmenorrhea involving administration of an estrogenic component which is preferably selected from the group consisting of estetrol and estetrol-like compounds. Estetrol-lik...
|
|
WO/2018/018783A1 |
A method for manufacturing a probiotics finishing agent, comprising the following steps: culturing probiotics; microencapsulating the probiotics; enabling the probiotics to be dormant; and blending an adhesive of microcapsules. The metho...
|
|
WO/2018/020013A1 |
The invention relates to a plant extract comprising a concentration, measured by the HPLC method, of at least 0.2 wt.% of safranal in relation to the total weight of the dry material. The invention also relates to a method for producing ...
|
|
WO/2018/016455A1 |
Disclosed is a composition for tonic strengthening, for sexual function improvement, for male menopausal symptom improvement, for a nourishing tonic, for improving vitality, for improving erectile dysfunction, for enhancement of cavernos...
|
|
WO/2018/015503A1 |
The invention relates to vaginal composition comprising a combination of estrogen and vitamin D or a vitamin D analog at a daily dosage delivery of (i) estrogen ranging from 1 μg to 100 μg estrogen of estradiol equivalent and (ii) vita...
|
|
WO/2018/006641A1 |
Provided is a traditional Chinese medicine for treating the edema caused by spleen deficiency with damp harassment in pregnant women. The traditional Chinese medicine is prepared by mixing the following raw materials in parts by weight: ...
|
|
WO/2018/006642A1 |
Provided is a TCM drug for treating pregnant women suffering from spleen deficiency and dampness stagnation. The TCM drug consists of the following raw materials: 15-30 g of Radix scrophulariae, 10-25 g of Atractylodes macrocephala, 20-3...
|
|
WO/2018/000665A1 |
Provided are an essential liquid for making breasts plump and firm and preventing breast diseases, and a method for preparing same, said essential liquid comprising: incense essential oil, rose essential oil, Pelargonium graveolens essen...
|
|
WO/2018/003997A1 |
The present invention addresses the problem of providing a safe and easy-to-prepare cell preparation for prevention and/or treatment of organ fibrosis such as liver fibrosis. Provided is a cell preparation for prevention and/or treatment...
|
|
WO/2017/223152A1 |
Embodiments of the present invention generally relate to methods for improving male fertility, and in particular for using sphingosine 1 phosphate (S I P) for improving the quality and/or longevity of sperm.
|
|
WO/2017/210836A1 |
An herbal wine formulation for tonifying kidney and invigorating qi using Radix Asparagi and Radix Ginseng, prepared using the following ingredients in the corresponding weights: 30-50 g of Radix Asparagi; 42-50 g of Radix Ginseng; 15-20...
|
|
WO/2017/214146A1 |
Methods and materials for treating bacterial vaginosis ("BV") are provided. Cervicovaginal secretions ("CVS") from a woman with vaginal microbiota dominated (>50%) by one of the species of lactobacillus typically found in the human vagin...
|
|
WO/2017/210989A1 |
Disclosed are a phloroglucinol-oxytocin injection and a preparation method therefor. Each 10,000 ml injection contains 100 ml of an oxytocin solution and 0.2 g of phloroglucinol, and a 1 ml injection contains 10 units of the oxytocin sol...
|
|
WO/2017/207481A1 |
The present application relates to the use of substituted indazoles for treatment and/or prophylaxis of allergic and/or inflammatory diseases in animals, especially for treatment and/or prophylaxis of atopic dermatitis, Flea Allergy Derm...
|
|
WO/2017/207705A1 |
The invention relates to a La-1-like peptide agent that increases sperm motility. It is non-toxic and it may be used to treat male infertility in humans, and also to increase fertility in animals. It may be used in artificial reproductiv...
|
|
WO/2017/203012A1 |
A compound which is (3R, 6R)-3-(2, 3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2, 6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S
)-1-methylpropyl]-2,5-piperazinedione: (I) or a pharmaceutically acceptable salt thereof for use in th...
|
|
WO/2017/201684A1 |
A combination of external medicines of an active ingredient I applied to a lesion and an active ingredient II applied to both sides of the chest. The active ingredient I consists of an immune protein powder and a traditional Chinese medi...
|
|
WO/2017/204316A1 |
The present invention provides a novel compound having P2X3 and/or P2X2/3 receptor antagonism. A compound represented by formula (I): (wherein, R1 represents a substituted or unsubstituted alkyl or the like, R2 represents a substituted o...
|
|
WO/2017/200413A1 |
The present invention relates to the treatment of urogenital infectious diseases caused by pathogenic microorganisms. A pharmaceutical composition or compositions contain 3,3'-diindolylmethane (DIM) or a derivative thereof, alone or in c...
|
|
WO/2017/201071A1 |
Pharmaceutical formulations containing a serotonin reuptake inhibitor and a smooth muscle relaxant are provided for the treatment of premature ejaculation and the increase in intravaginal ejaculatory latency time. Specific formulations c...
|
|
WO/2017/197790A1 |
A Rhizoma Gastrodiae and Radix Morindae Officinalis liquor, consisting of components of: Rhizoma Gastrodiae: 35 g; Radix Morindae Officinalis: 60 g; Flos Chrysanthemi: 60 g; Radix Rehmanniae Preparata: 50 g; Fructus Lycii: 30 g; Zanthoxy...
|
|
WO/2017/193509A1 |
Disclosed are a bionic gynecological lotion and a preparation method therefor. The lotion comprises a Musca domestica antibacterial peptide, a xylooligosaccharide, a xanthan gum and an artificial simulated vaginal secretion with a pH of ...
|
|
WO/2017/195090A1 |
The present invention relates to follicular fluid for use in in vitro fertilization, where said use comprises introducing follicular fluid in the uterus in one or more administrations during a time period comprised between six days befor...
|
|
WO/2017/190183A1 |
Provides herein are compositions for the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith, comprising an estrogen, optionally estriol, and a tricyclic antidepressant, optionally amitriptyli...
|
|
WO/2017/192713A1 |
The present invention relates to nutritional compositions for mothers and methods for birth and post-partum outcomes for infants of those mothers. More particularly, the general inventive concepts relate to the administration of a nutrit...
|
|
WO/2017/193000A1 |
A method is provided for treating a fatty acid oxidation metabolic condition, such as an inborn error of fatty acid oxidation or oxidative phosphorylation, and/or hypoglycemia, rhabdomyolysis, or cardiomyopathy in a patient. A mitochondr...
|
|
WO/2017/192847A1 |
Described are novel female fertility therapies. A first aspect of the invention is directed to therapies that include FSH lowering methodologies to prevent and/or treat egg infertility. A second aspect of the invention is directed to age...
|
|
WO/2017/192501A1 |
Disclosed are melanin compositions and devices, and methods of use thereof, to protect internal tissues and organs from radiation damage and to prevent or alleviate negative side effects associated with radiation exposure.
|
|
WO/2017/192841A1 |
The invention provides methods of treatment and combination therapies using heterobicyclic and related compounds that activate Gcase, such as in the treatment of endometriosis and Parkinson's disease. An exemplary heterobicyclic compound...
|
|
WO/2017/190107A1 |
Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, traumatic brain injury, and neuropathic pain.
|
|
WO/2017/186088A1 |
Disclosed are multiple pharmaceutical usages of a small-molecule hyaluronic acid fragment, comprising: treating tumors, conjunctival diseases, xerophthalmia, vitreous opacitees, myofascitis, arthrolithiasis, cardiovascular diseases, cere...
|
|
WO/2017/190109A1 |
Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, and neuropathic pain.
|
